Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Erwin

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 2, 2015
[Cryptococcal meningitis]W E Erwin van Spil, Suzan Nooijen, Peter Y P de Jong, et al.
Diagnostic Microbiology and Infectious Disease|November 22, 1997
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study GroupR N Jones, S A Marshall, M A Pfaller, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|February 1, 1991
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.
Journal of the American College of Radiology : JACR|February 25, 2016
Imaging Decision Support Does Not Drive Out-of-Network Leakage of Referred ImagingAnand M Prabhakar, H Benjamin Harvey, Alexander S Misono, et al.
Journal of Cardiac Surgery|November 1, 2022
Early mobilization in coronavirus-19 patients treated with extracorporeal membrane oxygenationTimothy J George, Jenelle Sheasby, Jeff E Taylor, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Nederlands Tijdschrift Voor Geneeskunde|April 2, 2015
[Cryptococcal meningitis]W E Erwin van Spil, Suzan Nooijen, Peter Y P de Jong, et al.
Diagnostic Microbiology and Infectious Disease|November 22, 1997
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study GroupR N Jones, S A Marshall, M A Pfaller, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|February 1, 1991
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.
Journal of the American College of Radiology : JACR|February 25, 2016
Imaging Decision Support Does Not Drive Out-of-Network Leakage of Referred ImagingAnand M Prabhakar, H Benjamin Harvey, Alexander S Misono, et al.
Journal of Cardiac Surgery|November 1, 2022
Early mobilization in coronavirus-19 patients treated with extracorporeal membrane oxygenationTimothy J George, Jenelle Sheasby, Jeff E Taylor, et al.
Pageof 16